India — Nuts and Edible Seeds — Groundnut

Higher risk. India ranks 1st of 3 origins shipping groundnut to the US on border rejections per $1 billion of US imports, at 672.8 — the highest of them.

least riskmost risk

← back to leaderboard

India received 19 FDA import refusals in Groundnut, part of Nuts and Edible Seeds between 2023-Q4 and 2026-Q3. Volume peaked at 7 in 2026-Q3, with the trend rising sharply year-on-year. The most-cited issues are mfr inj, salmonella, and mfr insan. Measured against US import value, that runs at 672.8 notifications per $1 billion of imports of this commodity from India over the last 3 years.

Of these, 18 were hazard refusals and 1 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

2 2023-Q4 2023-Q4: 2 2 2024-Q1 2024-Q1: 2 0 2024-Q2 2024-Q2: 0 1 2024-Q3 2024-Q3: 1 1 2024-Q4 2024-Q4: 1 0 2025-Q1 2025-Q1: 0 2 2025-Q2 2025-Q2: 2 1 2025-Q3 2025-Q3: 1 0 2025-Q4 2025-Q4: 0 1 2026-Q1 2026-Q1: 1 2 2026-Q2 2026-Q2: 2 7 2026-Q3 2026-Q3: 7

Recent rejections